Related references
Note: Only part of the references are listed.The antigen-binding moiety in the driver's seat of CARs
Heleen Hanssens et al.
MEDICINAL RESEARCH REVIEWS (2022)
A phycocyanin derived eicosapeptide attenuates lung fibrosis development
Qihao Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy
Fatemeh Oroojalian et al.
SMALL (2021)
Immunogenicity Risk Profile of Nanobodies
Chloe Ackaert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Directly reprogrammed natural killer cells for cancer immunotherapy
Han-Seop Kim et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Comprehensive characterization of the rRNA metabolism-related genes in human cancer
Kaisa Cui et al.
ONCOGENE (2020)
CAR-NK for tumor immunotherapy: Clinical transformation and future prospects
Wenxiu Wang et al.
CANCER LETTERS (2020)
Guanine-Stabilized Formamidinium Lead Iodide Perovskites
Li Hong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Increased Tumor Penetration of Single-Domain Antibody-Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models
Ian Nessler et al.
CANCER RESEARCH (2020)
Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours
Pieterjan Debie et al.
JOURNAL OF CONTROLLED RELEASE (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy
Xianwu Wang et al.
ACS CENTRAL SCIENCE (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Sialylation of Human Natural Killer (NK) Cells Is Regulated by IL-2
Philip Rosenstock et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Wen-Qi Cai et al.
FRONTIERS IN ONCOLOGY (2020)
CAR-NK cells: A promising cellular immunotherapy for cancer
Guozhu Xie et al.
EBIOMEDICINE (2020)
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Marcela Maus et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies
Joseph Tintelnot et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Aptamer-Engineered Natural Killer Cells for Cell-Specific Adaptive Immunotherapy
Shuanghui Yang et al.
SMALL (2019)
A New Isolate of Pediococcus pentosaceus (SL001) With Antibacterial Activity Against Fish Pathogens and Potency in Facilitating the Immunity and Growth Performance of Grass Carps
Liang Gong et al.
FRONTIERS IN MICROBIOLOGY (2019)
IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
Yeon Ho Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Novel Liposomal Azido Mannosamine Lipids on Metabolic Cell Labeling and Imaging via Cu-Free Click Chemistry
Li Shen et al.
BIOCONJUGATE CHEMISTRY (2019)
Site-specific C-terminal dinitrophenylation to reconstitute the antibody Fc functions for nanobodies
Haofei Hong et al.
CHEMICAL SCIENCE (2019)
CAR-Expressing Natural Killer Cells for Cancer Retargeting
Stephan Kloess et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
A guide to manufacturing CAR T cell therapies
Philipp Vormittag et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Programming CAR-T cells to kill cancer
Louai Labanieh et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Girdin/GIV regulates collective cancer cell migration by controlling cell adhesion and cytoskeletal organization
Xiaoze Wang et al.
CANCER SCIENCE (2018)
A Single-Step Chemoenzymatic Reaction for the Construction of Antibody-Cell Conjugates
Jie Li et al.
ACS CENTRAL SCIENCE (2018)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
Selective in vivo metabolic cell-labeling-mediated cancer targeting
Hua Wang et al.
NATURE CHEMICAL BIOLOGY (2017)
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Sourav Paul et al.
FRONTIERS IN IMMUNOLOGY (2017)
The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6
Yuan Yin et al.
CLINICAL CANCER RESEARCH (2017)
NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy
Garnet Suck et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Expanded and armed natural killer cells for cancer treatment
Noriko Shimasaki et al.
CYTOTHERAPY (2016)
Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
Gregory L. Beatty et al.
PHARMACOLOGY & THERAPEUTICS (2016)
NK cells and cancer: you can teach innate cells new tricks
Maelig G. Morvan et al.
NATURE REVIEWS CANCER (2016)
Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Yeh-Hsing Lao et al.
ACS NANO (2015)
Genetic manipulation of NK cells for cancer immunotherapy: techniques and clinical implications
Mattias Carlsten et al.
FRONTIERS IN IMMUNOLOGY (2015)
Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17
Jing Ren et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Comparison of alternative nucleophiles for Sortase A-mediated bioconjugation and application in neuronal cell labelling
Samuel Baer et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
Ignacio Melero et al.
CANCER DISCOVERY (2014)
Nanobodies: Natural Single-Domain Antibodies
Serge Muyldermans
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 82 (2013)
Sortase-Mediated Transpeptidation for Site-Specific Modification of Peptides, Glycopeptides, and Proteins
Zhimeng Wu et al.
JOURNAL OF CARBOHYDRATE CHEMISTRY (2012)
Dose dependence of intratumoral perivascular distribution of monoclonal antibodies
John J. Rhoden et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer
Baocheng Huang et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Strategies and challenges for the next generation of therapeutic antibodies
Alain Beck et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Sortase-Mediated Ligation: A Gift from Gram-Positive Bacteria to Protein Engineering
Shinya Tsukiji et al.
CHEMBIOCHEM (2009)
Natural killer cell-based immunotherapy in cancer: current insights and future prospects
T. Sutlu et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
C Imai et al.
BLOOD (2005)
Cell surface engineering by a modified Staudinger reaction
E Saxon et al.
SCIENCE (2000)
Share Paper
